WhatFinger

$4 generic antidepressant significantly reduces COVID-19 hospitalizations, clinical trial finds

By The Blaze ——--October 29, 2021

News Headlines | CFP Comments | Reader Friendly | Subscribe | Email Us

An inexpensive, generic antidepressant has been shown to significantly reduce the risk of severe COVID-19 in clinical trials. Fluvoxamine — a readily available pill used to treat depression and obsessive-compulsive disorder — dramatically reduces serious illness and death from COVID-19 when prescribed early, according to a study published in the journal Lancet Global Health.-- More...
Subscribe

View Comments
The Blaze——

Blaze Media is news and entertainment for people who love America. As one of the nation’s largest independent media companies, Blaze Media reaches over 165 million people each month through radio, podcasts, Roku, Amazon Fire, Apple TV, social media, email newsletters, and the web.

VIEW Comments

Sponsored
!-- END RC STICKY -->